Ardelyx [ARDX] vs Adaptive [ADPT] Detailed Stock Comparison
Ardelyx
NASDAQ
Loading...
Adaptive
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Ardelyx wins in 15 metrics, Adaptive wins in 3 metrics, with 0 ties. Ardelyx appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ardelyx | Adaptive | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -37.41 | -12.20 | Ardelyx |
| Price-to-Book Ratio | 10.97 | 11.16 | Ardelyx |
| Debt-to-Equity Ratio | 167.99 | 121.39 | Adaptive |
| PEG Ratio | -2.62 | 0.27 | Ardelyx |
| EV/EBITDA | -40.13 | -19.71 | Ardelyx |
| Profit Margin (TTM) | -14.60% | -59.07% | Ardelyx |
| Operating Margin (TTM) | -14.74% | -42.52% | Ardelyx |
| Return on Equity | -39.36% | -57.60% | Ardelyx |
| Return on Assets (TTM) | -6.23% | -14.00% | Ardelyx |
| Free Cash Flow (TTM) | $-45.82M | $-98.88M | Ardelyx |
| 1-Year Return | 2.91% | 180.43% | Adaptive |
| Price-to-Sales Ratio (TTM) | 3.97 | 9.78 | Ardelyx |
| Enterprise Value | $1.53B | $2.03B | Adaptive |
| EV/Revenue Ratio | 3.96 | 9.88 | Ardelyx |
| Gross Profit Margin (TTM) | 87.30% | 69.43% | Ardelyx |
| Revenue per Share (TTM) | $2 | $1 | Ardelyx |
| Earnings per Share (Diluted) | $-0.24 | $-0.81 | Ardelyx |
| Beta (Stock Volatility) | 0.68 | 1.93 | Ardelyx |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ardelyx vs Adaptive Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ardelyx | -0.31% | 4.09% | 50.71% | 57.82% | 18.66% | 24.22% |
| Adaptive | -0.98% | 1.38% | 26.85% | 41.57% | 59.56% | 112.92% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ardelyx | 2.91% | 483.49% | 10.23% | -66.33% | -55.56% | -55.56% |
| Adaptive | 180.43% | 51.15% | -63.17% | -72.71% | -72.71% | -72.71% |
Performance & Financial Health Analysis: Ardelyx vs Adaptive
| Metric | ARDX | ADPT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.53B | $2.01B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 3,241,860 | 1,767,150 |
| 90 Day Avg. Volume | 4,041,537 | 1,996,720 |
| Last Close | $6.36 | $13.18 |
| 52 Week Range | $3.21 - $7.18 | $3.98 - $13.52 |
| % from 52W High | -11.42% | -2.51% |
| All-Time High | $35.48 (Dec 01, 2014) | $71.25 (Jan 18, 2021) |
| % from All-Time High | -82.07% | -81.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.33% | 0.36% |
| Quarterly Earnings Growth | 0.33% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.15% | -0.59% |
| Operating Margin (TTM) | -0.15% | -0.43% |
| Return on Equity (TTM) | -0.39% | -0.58% |
| Debt to Equity (MRQ) | 167.99 | 121.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.58 | $1.18 |
| Cash per Share (MRQ) | $0.99 | $1.30 |
| Operating Cash Flow (TTM) | $-53,488,000 | $-80,470,000 |
| Levered Free Cash Flow (TTM) | $-11,269,125 | $-18,756,124 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ardelyx vs Adaptive
| Metric | ARDX | ADPT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -37.41 | -12.20 |
| Forward P/E | -90.86 | -14.02 |
| PEG Ratio | -2.62 | 0.27 |
| Price to Sales (TTM) | 3.97 | 9.78 |
| Price to Book (MRQ) | 10.97 | 11.16 |
| Market Capitalization | ||
| Market Capitalization | $1.53B | $2.01B |
| Enterprise Value | $1.53B | $2.03B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.96 | 9.88 |
| Enterprise to EBITDA | -40.13 | -19.71 |
| Risk & Other Metrics | ||
| Beta | 0.68 | 1.93 |
| Book Value per Share (MRQ) | $0.58 | $1.18 |
Financial Statements Comparison: Ardelyx vs Adaptive
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ARDX | ADPT |
|---|---|---|
| Revenue/Sales | $97.66M | $52.44M |
| Cost of Goods Sold | $12.40M | $16.98M |
| Gross Profit | $85.26M | $35.46M |
| Research & Development | $15.67M | $24.20M |
| Operating Income (EBIT) | $-14.40M | $-29.60M |
| EBITDA | $-11.87M | $-22.19M |
| Pre-Tax Income | $-19.08M | $-29.83M |
| Income Tax | $1,000 | N/A |
| Net Income (Profit) | $-19.08M | $-29.83M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ARDX | ADPT |
|---|---|---|
| Cash & Equivalents | $30.81M | $50.65M |
| Total Current Assets | $312.69M | $256.49M |
| Total Current Liabilities | $75.84M | $87.81M |
| Long-Term Debt | $153.81M | $76.44M |
| Total Shareholders Equity | $145.68M | $190.22M |
| Retained Earnings | $-926.48M | $-1.33B |
| Property, Plant & Equipment | $1.67M | $88.43M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ARDX | ADPT |
|---|---|---|
| Operating Cash Flow | $-32.99M | $-18.25M |
| Capital Expenditures | $-325,000 | $-1.26M |
| Free Cash Flow | $-38.78M | $-29.74M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ARDX | ADPT |
|---|---|---|
| Shares Short | 23.64M | 8.95M |
| Short Ratio | 5.58 | 4.36 |
| Short % of Float | 0.11% | 0.08% |
| Average Daily Volume (10 Day) | 3,241,860 | 1,767,150 |
| Average Daily Volume (90 Day) | 4,041,537 | 1,996,720 |
| Shares Outstanding | 238.02M | 147.77M |
| Float Shares | 232.61M | 117.37M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 0.71% | 0.98% |
Dividend Analysis & Yield Comparison: Ardelyx vs Adaptive
| Metric | ARDX | ADPT |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |